Clavitherapy in disseminated sclerosis - DS (sclerosis multiplex - SM),
in atrophic lateral slerosis (ALS), neuropathy and AIDS polyneuropathy

DISSEMINATED SCLEROSIS (sclerosis multiplex – SM) - symptoms and their causes


DISSEMINATED SCLEROSIS is very complex disorder, especially for an emotionally sensitive person.
The illness is characterised by a wide range of symptoms, of which not all need to appear in one affected patient. 

The results of the study of 200 patients diagnosed with Disseminated Slcerosis – DS
(Sclerosis Multiplex – SM) prior to and following clavitherapy:

1. Particular susceptibility for strong and prolonged emotional disturbances  172  6 / 169  not evaluated 3 
2. Cognitive impairments  181  6 / 169  „ 12 
3. Character related disturbances  185  6 / 177  „ 8 
4. Volitional disturbances  173   6 / 171   „ 2 
5. Neuroses: vegetative, anxiety and reactive depressive  191  6 / 188  „ 3 
6. Sleep disturbances and difficulty falling asleep  193  6 / 186  „ 7
7. Generally psychosomatic disturbances 198 6 / 194 „ 4
8. Nervous system disturbances  200  6 / 191  „ 9
9. Digestive system disturbances  199  6 / 197  „ 2
10. Low pressure (3 patients with hypertension)  177  6 / 172  „ 5
11. Impaired blood supply to the loins, buttocks and limbs  195  6 / 192  „ 3 
12. Cold feet and hands syndrome  189  4 / 189  „ 0 
13. Fragility of blood vessels  144  6 / 143  „ 1 
14. MRI confirmed demyelinisation in the brain  197  A second MRI examination was carried out in 3 patients and confirmed disappearance of demyelinisation in the brain.  A second MRI examination was carried out in 3 patients and confirmed disappearance of demyelinisation in the brain.  A second MRI examination was carried out in 3 patients and confirmed disappearance of demyelinisation in the brain.
15. Babinski sign  196  6 / 151  „ 45 
16. Lack of energy  194  6 / 187  „ 7 
17. Loss of moror drive, impotence  189  6 / 182  „ 7 
18. Dandruff  192  6 / 188  „ 4 
19. Tremor of the upper extremities and the head (ataxia)  32  6 / 29  „ 3 
20. Spasticity  179  6 / 174  „ 5 
21. Labirynth equilibrium disturbances  185  4 / 185  „ 0
22. Cerebellar equilibrium disturbances  185   4 / 185  „  0 
23. Ischaemic equilibrium disturbances  185   4 / 185  „  0 
24. Walk disturbances  183  6 / 174  „  9
25. Disturbances of nerve signal conduction  189   6 / 186   „  3
26. Weakening of the muscle dynamics  189  6 / 187  „  2
27. Dropping foot syndrome  171  6 / 163  „   8 
28. Vision disturbances  185  6 / 181  „  4
29. Movement precision disturbances  183  6 / 180   „  3 
30. Urination disturbances  187  6 / 182  „ 5 
31. Defecation disturbances  187  6 / 184   „  3 
32. Mobility disturbances  189  6 / 185  „ 4 
33. Aphasia  181  6 / 178   „  3 
34. Speech disturbances  102  6 / 99   3

35. Dysphagia

  136 6 / 134   2
36. Respiratory disturbances 196 3 / 193   3
37. Abnormal blood and urine test results 45 6 / 42   3
38. Abnormal ECG etc. Low pressure, arrhythmia 12 objective improvement6/11 no data 1
39. Acquired immunodeficiency syndrome not evaluated not evaluated   0
40. Bothersome pathological habits 187 6 / 181   6
41. Disturbances and defects of posture etc. 158 6 / 153   5
42. Stimulants, smoking 57 6 / 57   0

 

Next chapter >>

Appendix 1 - preliminary neurological evaluation of disseminated sclerosis - DS (sclerosis multiplex - SM) patients treated with clavitherapy method

C